Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer: A Phase II Study

NCT03781323 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT03781323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03781323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer: A Phase II Study
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 3, 2019
Completion date
June 1, 2027
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced rectal cancer